RALY - RALY heterogeneous nuclear ribonucleoprotein Gene

Also Known as P542; HNRPCL2

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 22913

About RALY

Cytogenetic location: 20q11.22 Genomic coordinates (GRCh38): 20:33,993,911-34,084,884 (from NCBI)

This gene has 10 transcripts (splice variants), 203 orthologues and 6 paralogues. Ubiquitous expression in bone marrow (RPKM 18.7), testis (RPKM 18.3) and 25 other tissues.

Summary

This gene encodes a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) gene family. This protein may play a role in pre-mRNA splicing and in embryonic development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]

RALY Products (2)

mRNA Protein Name
NM_007367.4 NP_031393.2 RNA-binding protein Raly isoform 2
NM_016732.3 NP_057951.1 RNA-binding protein Raly isoform 1

Gene Ontology

  • Molecular Function
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables protein binding IPI
IPI: Inferred from physical interaction
22365833 GOA
Cellular Component GO Annotation Evidence References Source
part of catalytic step 2 spliceosome IDA
IDA: Inferred from direct assay
11991638 GOA
located in nucleus IDA
IDA: Inferred from direct assay
22720776 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

RALY Protein Structure

RRM_1

RRM_1: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) (23 - 85)

  • 0
  • 100
  • 200
  • 306 a.a.
Protein Preferred Names Protein Names

RNA-binding protein Raly

  • RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog)

RALY Protein-protein interaction Information

Type
Protein Name Protein ID Interactor Interactor Species Interactor ID Detection Method References
Intra
RALY Q9UKM9 HNRNPC Homo sapiens P07910
Crosslink
30021884
Intra
RALY Q9UKM9 HNRNPC Homo sapiens P07910
Y2H
22365833
Intra
RALY Q9UKM9 HNRNPC Homo sapiens P07910
Anti Tag CoIP
33961781
Intra
RALY Q9UKM9 FUS Homo sapiens P35637
PLA
30354839
Intra
RALY Q9UKM9 FUS Homo sapiens P35637
IF
30354839
Intra
RALY Q9UKM9 FUS Homo sapiens P35637
Anti Tag CoIP
30354839
Intra
RALY Q9UKM9 HNRNPCL2 Homo sapiens B2RXH8
Crosslink
30021884
Cross: Cross-species interaction Intra: Intraspecies interaction

Related Diseases

Diseases Alias
Skin Carcinoma In Situ

  • Carcinoma In Situ Of Skin

  • Cutaneous Carcinoma In Situ
Bardet-Biedl Syndrome 1

  • BBS1

  • Bardet-Biedl Syndrome 1, Modifier Of

  • Bardet-Biedl Syndrome

  • BBS

  • Bardet-Biedl Syndrome, Type 1

  • Laurence-Moon-Bardet-Biedl Syndrome
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (11)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-15771 Tirabrutinib 99.71% Yes
HY-P3502 Zilucoplan Inhibitor 99.71% Unkown
HY-B0524 Betahistine Modulator 99.84% Unkown
HY-106019 Liarozole Inhibitor 98.96% Yes
HY-10405 Pamapimod Inhibitor 99.71% Unkown
HY-B0524A Betahistine dihydrochloride Modulator 99.82% Unkown
HY-17509 Deracoxib 99.96% Unkown
HY-15771A Tirabrutinib hydrochloride 99.66% Yes
HY-B0160 Lafutidine Antagonist 99.56% Unkown
HY-D0237 Betahistine mesylate Modulator 99.90% Unkown
HY-P3502A Zilucoplan TFA Inhibitor / Unkown
Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9924 Ixekizumab Inhibitor 99.00% Unkown
HY-P99661 Inbakicept Activator 99.06% Unkown

Clinical Phase

Bioactive Molecules (15)
Cat. No. Product Name Effect
Purity Phase
HY-P10284 S7 98.25% Phase 4
HY-10291 Tarenflurbil Inhibitor 99.95% Phase 3
HY-106019C Liarozole dihydrochloride Inhibitor 99.04% Phase 3
HY-14531 Talarozole Inhibitor 99.75% Phase 2
HY-150105 Icovamenib Inhibitor 98.96% Phase 2
HY-18099A S1RA hydrochloride Antagonist 99.76% Phase 2
HY-147264 Edecesertib Inhibitor 99.86% Phase 2
HY-18099 S1RA Antagonist 98.96% Phase 2
HY-101671 S-methyl-KE-298 98.0% Phase 2
HY-109034A Imarikiren hydrochloride Inhibitor / Phase 2
HY-155031 MCI Inhibitor / Phase 2
HY-163102 IA-14069 Inhibitor 99.93% Phase 1
HY-P10935A Amilo-5MER TFA Inhibitor 99.63% Phase 1
HY-106857A RA-octil / Phase 1
HY-P10935 Amilo-5MER Inhibitor / Phase 1
Inhibitory Antibodies (14)
Cat. No. Product Name Effect
Purity Phase
HY-P99252 Itolizumab ≥99.0% Phase 3
HY-P990983 Drotokibart Inhibitor 97.05% Phase 3
HY-P99870 Eblasakimab ≥99.0% Phase 2
HY-P99259 Cabiralizumab Inhibitor 99.73% Phase 2
HY-P99385 Vobarilizumab Inhibitor 99.9% Phase 2
HY-P991424 GSK2618960 Inhibitor 95.66% Phase 2
HY-P991266 SM-17 Inhibitor 96.98% Phase 2
HY-P99642 Gimsilumab Inhibitor 98.00% Phase 2
HY-P991596 ANB004 Antagonist / Phase 2
HY-P990086 Vopikitug Inhibitor 98.32% Phase 1
HY-P990647 PF-06342674 Inhibitor 99.69% Phase 1
HY-P991282 KHK2823 Inhibitor / Phase 1
HY-P991643 MTRX1011A Inhibitor / Phase 1
HY-P991937 SOL-116 Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (233)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-N0142 Phloretin Inhibitor 99.92% Unkown
HY-108521 HX531 99.87% Unkown
HY-P10136 IA9 Inhibitor 97.24% Unkown
HY-125099A AFM-30a hydrochloride Inhibitor 99.66% Unkown
HY-147141 HS-276 Inhibitor 98.93% Unkown
HY-111532 (3R,4R)-A2-32-01 Inhibitor 98.47% Unkown
HY-15898 Y-320 99.03% Unkown
HY-P1848 Pep-1 (uncapped) 99.89% Unkown
HY-N1440 Koumine Activator 99.97% Unkown
HY-N2435 [8]-Shogaol 99.93% Unkown
HY-110275 RA839 Inhibitor 98.54% Unkown
HY-W141394 Bz-OMe-rA 99.34% Unkown
HY-175701 CT-996 99.97% Unkown
HY-100739 RA190 Inhibitor 99.04% Unkown
HY-164416 DBCO-Dextran sulfate (MW 40000) 98.35% Unkown
HY-173117 RA306 Inhibitor 99.74% Unkown
HY-50081 CCR2-RA-[R] Antagonist 99.21% Unkown
HY-P10136A IA9 TFA Inhibitor 98.90% Unkown
HY-161762 RA-0002034 Inhibitor 99.48% Unkown
HY-N2506 Ginsenoside Ra1 99.88% Unkown
HY-108522 PA452 Antagonist ≥99.0% Unkown
HY-118530 Bucillamine Inhibitor 99.04% Yes
HY-147972 NF-κB/MAPK-IN-1 Inhibitor 98.71% Unkown
HY-N10790 RA-V 99.85% Unkown
HY-P0207A Endothelin-2 (49-69), human TFA Ligand 99.21% Unkown
HY-21545 5'-O-DMT-Bz-rA 98.0% Unkown
HY-103046 UbcH5c-IN-1 Inhibitor 99.84% Unkown
HY-15427 GDC-0834 Inhibitor 98.05% Unkown
HY-W006102 Bz-rA Phosphoramidite 99.03% Unkown
HY-136563 RA375 99.87% Unkown
HY-107730 NPY5RA-972 Antagonist 98.99% Unkown
HY-136528 RA-9 98.57% Unkown
HY-W008388 Bz-rA 99.51% Unkown
HY-103174 MRS1334 Antagonist 98.93% Unkown
HY-177435 FAPI-800CW Inhibitor 99.40% Unkown
HY-N0142R Phloretin (Standard) Inhibitor 98.15% Unkown
HY-P11287A DOTA-Pep-1L TFA Ligand 98.60% Unkown
HY-W641445 ELP-004 Inhibitor 99.89% Unkown
HY-139314 A2B receptor antagonist 2 Antagonist 99.60% Unkown
HY-400730 2'-O-POM-rA(Bz) 99.31% Unkown
HY-P3491 Pegloxenatide 90.00% Unkown
HY-100707 IC 86621 Inhibitor 99.06% Unkown
HY-114221 Org 48762-0 Inhibitor 99.99% Unkown
HY-125099 AFM-30a Inhibitor ≥96.0% Unkown
HY-N10793 RA-XI 96.45% Unkown
HY-N4259 Ginsenoside Ra3 99.91% Unkown
HY-N4260 Ginsenoside Ra2 99.87% Unkown
HY-164583 DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite 98.0% Unkown
HY-147660 IMMH001 Agonist 98.10% Unkown
HY-103177 PSB-10 hydrochloride Inhibitor / Unkown
HY-104017 DMT-2'-O-MOE-rA(Bz) phosphoramidite 98.0% Unkown
HY-125415 PF-4693627 Inhibitor 99.63% Unkown
HY-135378 Atorvastatin ethyl ester 98.16% Unkown
HY-15427A GDC-0834 Racemate 98.04% Unkown
HY-B0524AS1 Betahistine-13C,d3 dihydrochloride Modulator 99.55% Unkown
HY-P0207 Endothelin-2 (49-69), human Ligand 99.86% Unkown
HY-P10292 NOTA-Pep-1L 98.60% Unkown
HY-P10965 Zovaglutide Agonist / Unkown
HY-RS06737 IL22RA1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06764 IL3RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W018179 5'-DMT-3'-TBDMS-Bz-rA 99.19% Unkown
HY-13496 JNJ-28312141 Inhibitor / Unkown
HY-21703 3'-TBDMS-Bz-rA Phosphoramidite 98.38% Unkown
HY-N2876 Anisofolin A Inhibitor 98% Unkown
HY-RS18197 Il17ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS29519 C1ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W114886 DMT-OMe-rA(Bz) ≥97.0% Unkown
HY-W784549 N6-Me-rA phosphoramidite / Unkown
HY-B0524AS Betahistine-d3 dihydrochloride Modulator 99.0% Unkown
HY-106019A Liarozole hydrochloride Inhibitor / Unkown
HY-106618 Mopidamol Inhibitor / Unkown
HY-107495 Betahistine EP Impurity C Modulator 98.38% Unkown
HY-107644 AQ-RA 741 Antagonist / Unkown
HY-116472 alpha-RA-F / Unkown
HY-118689 RA-2 Modulator / Unkown
HY-118761 5,6-Epoxyretinoic acid Agonist / Unkown
HY-119291 RA642 Inhibitor / Unkown
HY-120785A SR1555 hydrochloride Antagonist / Unkown
HY-121500 R-116010 Inhibitor / Unkown
HY-123019 RA-263 / Unkown
HY-126640 Phomoxanthone A Inhibitor / Unkown
HY-126862 AQ-RA 721 Antagonist / Unkown
HY-127150 Clofezone Inhibitor / Unkown
HY-13496A JNJ-28312141 hydrochloride Inhibitor / Unkown
HY-135453 (-)-Pinocembrin Inhibitor 99.93% Unkown
HY-139654 α/β-Hydrolase-IN-1 Inhibitor / Unkown
HY-143290 Antibacterial agent 118 Inhibitor / Unkown
HY-146104 Antimycobacterial agent-1 Inhibitor / Unkown
HY-147141A HS-276 hydrochloride Inhibitor / Unkown
HY-147141B HS-276 formic Inhibitor / Unkown
HY-14750 Rabeximod / Unkown
HY-148543 FC-99 Inhibitor / Unkown
HY-149064 Antituberculosis agent-9 Inhibitor / Unkown
HY-149581 DprE1-IN-9 Inhibitor / Unkown
HY-150658S DMT-2′O-TBDMS-rA(ac) phosphoramidite-15N / Unkown
HY-150658S1 DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C2 / Unkown
HY-150658S2 DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C3 / Unkown
HY-150658S4 DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C10 / Unkown
HY-150658S5 DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C10,15N5 / Unkown
HY-150658S6 DMT-2′O-TBDMS-rA(ac) phosphoramidite-15N5 / Unkown
HY-150658S7 DMT-2′O-TBDMS-rA(ac) phosphoramidite-d9 / Unkown
HY-151472 hCAIX/XII-IN-6 Inhibitor / Unkown
HY-152035 Mycobacterial Zmp1-IN-1 Inhibitor / Unkown
HY-153333 A1/A3 AR antagonist 3 Antagonist / Unkown
HY-153489 ISIS 329993 Inhibitor / Unkown
HY-153489A ISIS 329993 sodium Inhibitor / Unkown
HY-154961 Mcl-1 inhibitor 14 / Unkown
HY-154962 Mcl-1 inhibitor 15 Inhibitor / Unkown
HY-161762A (E/Z)-RA-0002034 Inhibitor / Unkown
HY-163533 CPD-002 Inhibitor / Unkown
HY-163750 KMU-11342 Inhibitor / Unkown
HY-167905 ATL444 Antagonist / Unkown
HY-170806 ERα degrader 12 Degrader / Unkown
HY-172176 RA-PR058 Inhibitor / Unkown
HY-173321 PAD4-IN-5 Inhibitor / Unkown
HY-173518 SIN 14 / Unkown
HY-175310S Voderdeucitinib Inhibitor / Unkown
HY-176251 CBP/p300-IN-22 Inhibitor / Unkown
HY-176755 CCL-34 Activator / Unkown
HY-178230 EVT-401 Agonist / Unkown
HY-178714 JNJ627 Inhibitor / Unkown
HY-179173S DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C / Unkown
HY-181499 RA190-PEG1-NH2 / Unkown
HY-181523 RA183 Ligand / Unkown
HY-181524 RA183-CO-C6-NHCO-NH-Boc Ligand / Unkown
HY-182415 RX-RA-69 Inhibitor / Unkown
HY-50084 CCR2-RA Antagonist / Unkown
HY-B0160S Lafutidine-d10 Antagonist / Unkown
HY-D2279 NFL-NH2 / Unkown
HY-N11226 Ginsenoside Ra0 / Unkown
HY-N11646 Ganorbiformin B Inhibitor / Unkown
HY-N11650 (22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid Inhibitor / Unkown
HY-N11957 Angeloylbinankadsurin A / Unkown
HY-N12648 Anemarsaponin E1 / Unkown
HY-N16465 Cinnamtannin D1 Inhibitor / Unkown
HY-N19123 Ginsenoside Ra9 / Unkown
HY-N3612 Communic acid Inhibitor / Unkown
HY-P11046 IIIM1 Modulator / Unkown
HY-P11287 DOTA-Pep-1L Ligand / Unkown
HY-P2045 RA-VII / Unkown
HY-P2642 Peptide 78 98.13% Unkown
HY-RS03232 CSF2RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06673 IL10RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06676 IL11RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06688 IL13RA1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06689 IL13RA2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06693 IL15RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06702 IL17RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06732 IL20RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06738 IL22RA2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06747 IL27RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06748 IL2RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06755 IL31RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06773 IL5RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS11635 RALY Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-U00449A AGN 193109 sodium Antagonist / Unkown
HY-W748468 6-Isopentenyloxyisobergapten Inhibitor / Unkown
HY-104017R DMT-2'-O-MOE-rA(Bz) phosphoramidite (Standard) / Unkown
HY-105934A Ketotrexate sodium / Unkown
HY-113721 BML-244 Inhibitor / Unkown
HY-125068 RPR203494 Inhibitor / Unkown
HY-134075 2-Amino-2'-O-methyladenosine / Unkown
HY-134076 2',3'-Di-O-Methyladenosine / Unkown
HY-135376 Atorvastatin methyl ester 98.76% Unkown
HY-137007 SMA-12b Inhibitor / Unkown
HY-162707 RA-0002323-01 Inhibitor / Unkown
HY-172397 Mycobacterium Tuberculosis-IN-7 Inhibitor / Unkown
HY-173071 DprE1-IN-13 Inhibitor / Unkown
HY-174601 Human IL5RA mRNA / Unkown
HY-174605 Human IL3RA mRNA / Unkown
HY-174611 Human IL2RA mRNA / Unkown
HY-174612 Human IL27RA mRNA / Unkown
HY-174618 Human IL22RA2 mRNA / Unkown
HY-174619 Human IL22RA1 mRNA / Unkown
HY-174623 Human IL20RA mRNA / Unkown
HY-174632 Human IL17RA mRNA / Unkown
HY-174635 Human IL15RA mRNA / Unkown
HY-174637 Human IL13RA2 mRNA / Unkown
HY-174638 Human IL13RA1 mRNA / Unkown
HY-174643 Human IL11RA mRNA / Unkown
HY-174645 Human IL10RA mRNA / Unkown
HY-174733 Human CSF2RA mRNA / Unkown
HY-176268 SGC-NSP2hel-1 Inhibitor / Unkown
HY-178105 LQFM326 Inhibitor / Unkown
HY-178526 DMTr-2'-O-Me-6-Deamino-6-(m-benzenepropanoic acid 2-cyanoethyl ester)-rA-3'-CE-phosphoramidite / Unkown
HY-178527 DMTr-2'-O-Me-rA(Bz)-3'-(L)-DPSE-phosphoramidite / Unkown
HY-178568 DMTr-S-5-C-Me-2'-O-Me-rA(Bz)-3'-CE-phosphoramidite / Unkown
HY-178595 DMTr-2'-O-Me-rA(Bz)-3'-(L)-PSM-phosphoramidite / Unkown
HY-178599 DMTr-2'-O-[2-TFAAminoethoxymethyl]-rA(Bz)-3'-CE-phosphoramidite / Unkown
HY-178617 5'-O-DMTr-2'-O-(2-cyanoethoxymethyl)-rA(Ac) / Unkown
HY-178627 5'-O-DMTr-2'-O-TOM-rA(Ac) / Unkown
HY-178629 DMTr-2'-O-propyl-rA(Bz)-3'-CE-phosphoramidite / Unkown
HY-178632 2'-O-Me-7-deaza-rA / Unkown
HY-178648 DMTr-2'-O-Me-rA(Bz)-3'-(D)-DPSE-phosphoramidite / Unkown
HY-178652 5'-O-Bz-rA(Bz) / Unkown
HY-178655 DMTr-2'-O-C6-rA(Bz)-3'-CE-phosphoramidite / Unkown
HY-178660 DMTr-R-5'-C-Me-2'-O-Me-rA(Bz)-3'-CE-phosphoramidite / Unkown
HY-178661 DMTr-2'-O-TOM-N2-MeOAc-N6-iBu-rA-3'-CE-phosphoramidite / Unkown
HY-178669 5'-O-DMTr-3'-O-Me-rA(Bz) / Unkown
HY-178686 DMTr-2'-O-Me-rA(Bz)-3'-(D)-PSM-phosphoramidite / Unkown
HY-179532 Antimycobacterial agent-14 Inhibitor / Unkown
HY-18016 CGI 560 Inhibitor / Unkown
HY-43049 DMT-2'O-TBDMS-rA(bz) Phosphoramidite enantiomer / Unkown
HY-N12015 Ginsenoside Ra6 / Unkown
HY-RS17431 Il10ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18089 Csf2ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18438 Il13ra2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18825 Il2ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19279 Il13ra1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19373 Raly Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19696 Il5ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19780 Il15ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20169 Il27ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20557 Il31ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS21241 Il22ra1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS21870 Il20ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23886 Il10ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24563 Csf2ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24671 Il17ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24920 Il13ra2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS25315 Il2ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS25769 Il13ra1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS25865 Raly Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26191 Il5ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26277 Il15ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26673 Il27ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS27066 Il31ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS27758 Il22ra1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS28387 Il20ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-U00420 Opioid receptor modulator 1 Modulator / Unkown
HY-W1008069 3'-TBS-OMe-Bz-rA / Unkown
HY-W1121763 DMT-2'O-TC-rA(bz) Phosphoramidite / Unkown
HY-W754015 5'-O-DMTr-2'-O-Me-rA 99.88% Unkown
Inhibitory Antibodies (27)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P9923A Benralizumab (anti-IL5RA ) Inducer 99.60% Unkown
HY-P990016 Temtokibart Inhibitor 99.23% Unkown
HY-P991219 Anti-IL11RA Antibody (X209) Inhibitor 97.75% Unkown
HY-P990166 Anti-Mouse PSGL-1/CD162 Antibody (4RA10) Inhibitor ≥95.0% Unkown
HY-P990713 Nolavetbart 96% Unkown
HY-P99287 Elsilimomab Inhibitor 98.44% Unkown
HY-P990662 Sapelizumab Inhibitor 98.31% Unkown
HY-P991513 BI-655064 Inhibitor 98.56% Unkown
HY-P990299 Anti-Mouse B220 Antibody (RA3.3A1/6.1) Inhibitor ≥95% Unkown
HY-P99782 Opinercept Inhibitor / Unkown
HY-P991688 Gimvekibart Inhibitor 95.50% Unkown
HY-P991699 Lixarkitug Inhibitor 99% Unkown
HY-P99487 Briobacept 97.66% Unkown
HY-P991005 Larnefpendekin alfa Inhibitor / Unkown
HY-P990451 Anti-IL-3Ra/CD123 Antibody (SNG-CD123A) Inhibitor 95.01% Unkown
HY-P990547 APX-007 Inhibitor / Unkown
HY-P990776 Vimekofusp / Unkown
HY-P991593 ABT-147 Inhibitor / Unkown
HY-P991600 Anti-IL-6 Antibody (Chugai SK2) Inhibitor / Unkown
HY-P992004 KHK2805 Inhibitor / Unkown
HY-P992028 Anti-IL-1RA Antibody Inhibitor / Unkown
HY-P992032 TPP-9476 Antagonist / Unkown
HY-P992161 REGN-10597 / Unkown
HY-P992235 Anti-IL11RA Antibody (Hu16E12) Inhibitor / Unkown
HY-P992239 Anti-IL-18Rα Antibody / Unkown
HY-P992246 Anti-IL-27RA Antibody / Unkown
HY-P99790 Priliximab / Unkown

Orthologs Information

Species Symbol Source ID
Mus musculus RALY MGD MGI:97850
Bos taurus RALY VGNC VGNC:33706
Rattus norvegicus RALY RGD RGD:1307228
Canis familiaris RALY VGNC VGNC:45337
Felis catus RALY VGNC VGNC:81167
Macaca mulatta RALY VGNC VGNC:76486
Others RALY NCBI